Cancer TreatmentDrugs Daratumumab A Targeted Therapy for Hematologic Cancers Tony Gates October 29, 2024 Daratumumab, a monoclonal antibody targeting CD38, has revolutionized the treatment landscape for hematologic malignancies. Its unique mechanism of action, selectively targeting CD38 expressed on the